NOT KNOWN FACTS ABOUT LINK ALTERNATIF MBL77

mutations offered The point that, as described below, CLL therapy relies on the presence or absence of such mutations. The existing consensus is always that, apart from clonal mutations, subclonal mutations by using a variant allelic frequency starting from 5 to 10% (and therefore beneath the edge of detection by conventional molecular tactics) cou